News & Media / Press Releases

WBB Securities Acts as Financial Advisor on $60 Million Loan for Navidea Biopharmaceuticals

May 11, 2015

WBB Securities acted as financial advisor to Navidea Biopharmaceuticals regarding a term loan with CRG (formerly Capital Royalty LP). Under the terms of the agreement, CRG will provide Navidea with initial funding of $50 million.

Continue Reading

WBB Securities Acts as Placement Agent for up to $25 Million in Equity Financing for Cytori Therapeutics

May 8, 2015

WBB Securities acted as placement agent to a transaction for Cytori Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing autologous cell therapies from adipose tissue to treat a variety of medical conditions.

Continue Reading

WBB Securities Sponsors BioCentury’s Future Leaders in the Biotech Industry Conference

March 20, 2015

Today WBB Securities sponsored BioCentury’s Future Leaders in the Biotech Industry conference held at the Millennium Broadway Hotel and Conference Center in New York City.

Continue Reading

WBB Securities Co-Manages $84 Million Public Offering for Omeros Corporation

February 4, 2015

WBB Securities acted as co-manager to a transaction for Omeros Corporation in an underwritten public offering that closed on February 3, 2015.

Continue Reading

WBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents Corporation

January 15, 2015

CytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities

Continue Reading

WBB Securities Announces Michelle Thomas Elected to FINRA District 2 Committee

December 8, 2014

WBB Securities is pleased to announce that Michelle Thomas, CRCPhas been elected to the FINRA District 2 Committee where she will serve a three-year term.

Continue Reading

WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility

September 29, 2014

NeoStem announces $20 million term loan financing from Oxford Finance LLC

Continue Reading

WBB Securities Sponsors BioCentury’s 21st Annual NewsMakers Conference

September 29, 2014

Executive Teams of Emerging Biotech Companies Present to Investor Community

Continue Reading

WBB Securities Acts as Co-manager to TetraLogic Pharmaceuticals on $47MM Convertible Senior Notes Transaction

June 25, 2014

WBB Securities acted as co-manager on a convertible senior notes transaction for TetraLogic Pharmaceuticals, Inc.

Continue Reading

WBB Securities Acts as Exclusive Placement Agent to Cytori Therapeutics

June 6, 2014

WBB Securities acted as exclusive placement agent on a registered direct financing for Cytori Therapeutics, a clinical phase regenerative medicine company.

Continue Reading